Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis (Q33969694)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis
scientific article

    Statements

    title
    Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21784637
    retrieved
    30 July 2017
    author name string
    Antonis Valachis
    series ordinal
    1
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21784637
    retrieved
    30 July 2017
    Davide Mauri
    series ordinal
    2
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21784637
    retrieved
    30 July 2017
    Nikolaos P Polyzos
    series ordinal
    3
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21784637
    retrieved
    30 July 2017
    Grigoris Chlouverakis
    series ordinal
    4
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21784637
    retrieved
    30 July 2017
    Dimitrios Mavroudis
    series ordinal
    5
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21784637
    retrieved
    30 July 2017
    Vassilios Georgoulias
    series ordinal
    6
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21784637
    retrieved
    30 July 2017

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q33969694&oldid=1970919678"